KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Progyny (PGNY) EPS (Weighted Average and Diluted) (2019 - 2025)

Progyny (PGNY) has disclosed EPS (Weighted Average and Diluted) for 7 consecutive years, with $0.31 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) changed N/A to $0.31 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.31, a N/A change, with the full-year FY2025 number at $0.89, up 56.01% from a year prior.
  • EPS (Weighted Average and Diluted) was $0.31 for Q4 2025 at Progyny, up from $0.15 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.31 in Q4 2025 to a low of $0.03 in Q4 2022.
  • A 5-year average of $0.15 and a median of $0.15 in 2021 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): skyrocketed 2000.0% in 2021, then crashed 80.0% in 2022.
  • Progyny's EPS (Weighted Average and Diluted) stood at $0.15 in 2021, then plummeted by 80.0% to $0.03 in 2022, then skyrocketed by 333.33% to $0.13 in 2023, then dropped by 15.38% to $0.11 in 2024, then skyrocketed by 185.69% to $0.31 in 2025.
  • Per Business Quant, the three most recent readings for PGNY's EPS (Weighted Average and Diluted) are $0.31 (Q4 2025), $0.15 (Q3 2025), and $0.19 (Q2 2025).